版本:
中国

BRIEF-Asterias Biotherapeutics Q4 loss per share $0.20

March 28 Asterias Biotherapeutics Inc:

* Asterias Biotherapeutics reports fourth quarter and full year 2016 financial results and highlights recent development progress

* Q4 loss per share $0.20

* Q4 revenue $1.8 million

* Q4 revenue view $2.6 million -- Thomson Reuters I/B/E/S

* Q4 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S

* Asterias Biotherapeutics Inc- "believe we currently have sufficient capital to fund operations through at least q1 of 2018" Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐